Last mentioned: Mar 19, 2026
CFO Appointment
Bambusa Therapeutics officially announces Todd James as the new Chief Financial Officer.
Industry Tenure
Todd James builds 20+ years of experience in biopharmaceutical leadership and finance.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical industry veteran with over 20 years of experience, as its new Chief Financial Officer. The strategic hire signals a focus on strengthening capital markets expertise and investor relations as the company advances its therapeutic pipeline.
Bambusa Therapeutics has appointed Todd James, a biopharmaceutical executive with over two decades of experience, as its new Chief Financial Officer. The move signals a strategic focus on capital markets and investor relations as the company prepares for its next phase of growth.